ConductScience.org, home

Paper23782898

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.

Pybus BS and 13 others. Malar J, 2013. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Papers, record 23782898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23782898

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
PubMed
Journal
Malar J
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
5.47
iCite
Revised in PubMed
2021-10-21
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pybus BSBrandon S
2Marcsisin SRSean R
3Jin XXiannu
4Deye GGregory
5Sousa JCJason C
6Li QQigui
7Caridha DDiana
8Zeng QQiang
9Reichard GAGregory A
10Ockenhouse CChristian
11Bennett JJason
12Walker LALarry A
13Ohrt CColin
14Melendez VVictor

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
Cytochrome P-450 CYP2D6Major topic
PrimaquineMajor topic
Animals
Hydroxylation
Malaria
Male
Mice
Mice, Inbred BALB C
Mice, Knockout
Plasmodium berghei

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02898779Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1ResultsClinicalTrials.gov
NCT05071079A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected ErythrocytesBackgroundClinicalTrials.gov

Download CSV of trials

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122144436Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.Am J Trop Med Hyg2011https://conductscience.org/library/papers/22144436PubMed
211972444CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.Pharmacogenomics2002https://conductscience.org/library/papers/11972444PubMed
311303037Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11303037PubMed
41313024Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling.J Biol Chem1992https://conductscience.org/library/papers/1313024PubMed
518930565Primaquine revisited six decades after its discovery.Eur J Med Chem2009https://conductscience.org/library/papers/18930565PubMed
623130957Rationale for short course primaquine in Africa to interrupt malaria transmission.Malar J2012https://conductscience.org/library/papers/23130957PubMed
714618296Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.Naunyn Schmiedebergs Arch Pharmacol2004https://conductscience.org/library/papers/14618296PubMed
821171195How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.Curr Drug Metab2010https://conductscience.org/library/papers/21171195PubMed
921989258Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines.Mol Pharmacol2012https://conductscience.org/library/papers/21989258PubMed
10170753408-Aminoquinolines: future role as antiprotozoal drugs.Curr Opin Infect Dis2006https://conductscience.org/library/papers/17075340PubMed
1119616568Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.Toxicol Appl Pharmacol2009https://conductscience.org/library/papers/19616568PubMed
1210445386Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.Exp Toxicol Pathol1999https://conductscience.org/library/papers/10445386PubMed
137720510Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.Drug Metab Dispos1995https://conductscience.org/library/papers/7720510PubMed
1414724225Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.J Pharmacol Exp Ther2004https://conductscience.org/library/papers/14724225PubMed
1522972117Primaquine for reducing Plasmodium falciparum transmission.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22972117PubMed
1622662135Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.PLoS One2012https://conductscience.org/library/papers/22662135PubMed
1712438535Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.J Pharmacol Exp Ther2002https://conductscience.org/library/papers/12438535PubMed
1812235244Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.J Pharmacol Exp Ther2002https://conductscience.org/library/papers/12235244PubMed
1922856549CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.Malar J2012https://conductscience.org/library/papers/22856549PubMed
204060148Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.Toxicol Appl Pharmacol1985https://conductscience.org/library/papers/4060148PubMed

See all 22 referencesDownload CSV of references

Cited by114

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42888416CYP3A and CYP2D6 variability in antimalarial pharmacokinetics and pharmacogenetics across populations: a narrative review.Malar J2026https://conductscience.org/library/papers/42888416PubMed
42531257An orally available PfPKG inhibitor blocks Plasmodium's infection of the liver.PLoS Pathog2026https://conductscience.org/library/papers/42531257PubMed
42439801Primaquine-derived 5,6-orthoquinone concentrations in urine associated with CYP2D6 genotype-predicted phenotype and blood methemoglobin levels.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42439801PubMed
42037398Differential impact of Tafenoquine and Primaquine on Plasmodium vivax recurrence: the role of CYP2D6 variants.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42037398PubMed
41320957Humanization of Drug Metabolism in the Plasmodium berghei Mouse Model for Antimalarial Drug Discovery.ACS Infect Dis2025https://conductscience.org/library/papers/41320957PubMed
41097408Discovery of Primaquine-Indole Carboxamides with Cancer-Cell-Selective Antiproliferative Activity.Molecules2025https://conductscience.org/library/papers/41097408PubMed
41028863Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination.Sci Rep2025https://conductscience.org/library/papers/41028863PubMed
40827872How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil.J Infect Dis2025https://conductscience.org/library/papers/40827872PubMed
40420292Natural products as transmission-blocking agents against malaria: a comprehensive review of bioactive compounds and their therapeutic potential.Malar J2025https://conductscience.org/library/papers/40420292PubMed
40316617Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon.Sci Rep2025https://conductscience.org/library/papers/40316617PubMed
38870082Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.J Antimicrob Chemother2024https://conductscience.org/library/papers/38870082PubMed
38719803Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants.Nat Commun2024https://conductscience.org/library/papers/38719803PubMed
38640243Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure.Sci Adv2024https://conductscience.org/library/papers/38640243PubMed
38411047Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR).Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38411047PubMed
37971260Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against Plasmodium vivax in Australian Defence Force personnel.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/37971260PubMed
37652975Antimalarial drug discovery: progress and approaches.Nat Rev Drug Discov2023https://conductscience.org/library/papers/37652975PubMed
37638690Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.J Antimicrob Chemother2023https://conductscience.org/library/papers/37638690PubMed
36928885Development of an ectopic huLiver model for Plasmodium liver stage infection.PLoS One2023https://conductscience.org/library/papers/36928885PubMed
36726785Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration.Front Pharmacol2022https://conductscience.org/library/papers/36726785PubMed
36321830A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/36321830PubMed

See all 114 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
PPIG9360PubTator's text mininghttps://conductscience.org/library/genes/9360NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
PRIMAQUINECHEMBL506Results1https://conductscience.org/library/drugs/CHEMBL506

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23782898

GET https://conductscience.org/api/papers/v1/23782898/references?page=2